Search

Your search keyword '"Crum, Christopher P."' showing total 1,265 results
Start Over Author "Crum, Christopher P."
1,265 results on '"Crum, Christopher P."'

3. Uterus

Author

Grifone, Thomas J., Crum, Christopher P., Lin, Fan, editor, Prichard, Jeffrey W., editor, Liu, Haiyan, editor, and Wilkerson, Myra L., editor

Published
2022
Full Text
View/download PDF

4. STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for STK11 adnexal tumours.

Author

Dehghani, Amir, Sharma, Aarti E, Siegmund, Stephanie E, Carreon, Chrystalle K, Stewart, Colin J R, Medeiros, Fabiola, Mirkovic, Jelena, Nucci, Marisa R, Crum, Christopher P, Hornick, Jason L, Howitt, Brooke E, McCluggage, W Glenn, and Kolin, David L

Subjects
MUCINOUS adenocarcinoma, GRANULOSA cells, SERTOLI cells, LEYDIG cells, ELECTRONIC publications, FALLOPIAN tubes
Abstract

Aims: STK11 adnexal tumour is a rare, recently described malignant neoplasm that is associated with Peutz–Jeghers syndrome. [Correction added on 3 October 2024, after first online publication: 'ST11' in preceding sentence has been corrected to 'STK11' in this version.] It predominantly originates from the para‐adnexal soft tissues and often shows secondary involvement of the fallopian tube and ovary. STK11 adnexal tumours have a broad differential diagnosis due to their variable morphology and non‐specific immunoprofile, and diagnostic confirmation currently requires sequencing to identify an STK11 mutation. We investigate the diagnostic utility of STK11 (LKB1) immunohistochemistry (IHC) in a cohort of STK11 adnexal tumours and morphological mimics. Methods and results: IHC for STK11 was performed on 122 tumours, including 17 STK11 adnexal tumours and 105 morphological mimics (10 female adnexal tumours of Wolffian origin, 22 adult granulosa cell tumours, 10 juvenile granulosa cell tumours, four Sertoli–Leydig cell tumours, two Leydig cell tumours, one Sertoli cell tumour, one steroid cell tumour, four extra‐ovarian sex cord‐stromal tumours, 16 ovarian endometrioid carcinomas, eight tubo‐ovarian high‐grade serous carcinomas, five ovarian mesonephric‐like adenocarcinomas, 14 ovarian carcinosarcomas, five peritoneal malignant mesotheliomas, two pelvic plexiform leiomyomata and one ovarian solid pseudopapillary tumour). All STK11 adnexal tumours showed complete loss of cytoplasmic staining for STK11. All other tumour types showed retained cytoplasmic staining, except for one endometrioid carcinoma with mucinous differentiation which showed complete loss of STK11 expression and a high‐grade serous carcinoma with subclonal loss. Conclusions: STK11 is a highly sensitive and specific immunohistochemical marker for distinguishing STK11 adnexal tumour from its histological mimics, and can obviate the need for confirmatory molecular studies in the appropriate morphological context. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Cloning of ground-state intestinal stem cells from endoscopic biopsy samples

Author

Duleba, Marcin, Yamamoto, Yusuke, Neupane, Rahul, Rao, Wei, Xie, Jingzhong, Qi, Yutao, Liew, Audrey-Ann, Niroula, Suchan, Zhang, Yanting, Mahalingam, Rajasekaran, Wang, Shan, Goller, Kristina, Ajani, Jaffer A., Vincent, Matthew, Ho, Khek Yu, Hou, Jason K., Hyams, Jeffrey S., Sylvester, Francisco A., Crum, Christopher P., McKeon, Frank, and Xian, Wa

Published
2020
Full Text
View/download PDF

11. Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

Author

Novak, Marián, Lester, Jenny, Karst, Alison M, Parkash, Vinita, Hirsch, Michelle S, Crum, Christopher P, Karlan, Beth Y, and Drapkin, Ronny

Subjects
Cancer, Biomarkers, Tumor, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p16, Cystadenocarcinoma, Serous, Fallopian Tube Neoplasms, Female, Gene Knockdown Techniques, Humans, Immunohistochemistry, Ki-67 Antigen, Mutation, Neoplasm Proteins, Ovarian Neoplasms, Stathmin, Tumor Suppressor Protein p53, Ovarian, Serous, Fallopian tube, STIC, p16, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis
Abstract

ObjectiveTo credential Stathmin 1 (STMN1) and p16(INK4A) (p16) as adjunct markers for the diagnosis of serous tubal intraepithelial carcinoma (STIC), and to compare STMN1 and p16 expression in p53-positive and p53-negative STIC and invasive high-grade serous carcinoma (HGSC).MethodsImmunohistochemistry (IHC) was used to examine STMN1 and p16 expression in fallopian tube specimens (n=31) containing p53-positive and p53-negative STICs, invasive HGSCs, and morphologically normal FTE (fallopian tube epithelium). STMN1 and p16 expression was scored semiquantitatively by four individuals. The semiquantitative scores were dichotomized, and reported as positive or negative. Pooled siRNA was used to knockdown p53 in a panel of cell lines derived from immortalized FTE and HGSC.ResultsSTMN1 and p16 were expressed in the majority of p53-positive and p53-negative STICs and concomitant invasive HGSCs, but only scattered positive cells were present in morphologically normal FTE. Both proteins were expressed consistently across multiple STICs from the same patient and in concomitant invasive HGSC. Knockdown of p53 in immortalized FTE cells and in four HGSC-derived cell lines expressing different missense p53 mutations did not affect STMN1 protein levels.ConclusionsThis study demonstrates that STMN1 and p16 are sensitive and specific adjunct biomarkers that, when used with p53 and Ki-67, improve the diagnostic accuracy of STIC. The addition of STMN1 and p16 helps to compensate for practical limitations of p53 and Ki-67 that complicate the diagnosis in up to one third of STICs.

Published
2015

15. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lung Is Not Resolved by CFTR Modulators

Author

Wang, Shan, primary, Niroula, Suchan, additional, Hoffman, Ashley, additional, Khorrami, Melika, additional, Khorrami, Melina, additional, Yuan, Feng, additional, Gasser, Grace N, additional, Choi, Soon, additional, Liu, Bovey, additional, Li, Justin, additional, Metersky, Mark L, additional, Vincent, Matthew, additional, Crum, Christopher P, additional, Boucher, Richard C, additional, Karmouty-Quintana, Harry, additional, Huang, Howard J, additional, Sheshadri, Ajay, additional, Dickey, Burton F, additional, Parekh, Kalpaj R, additional, Engelhardt, John F, additional, McKeon, Frank D, additional, and Xian, Wa, additional

Published
2023
Full Text
View/download PDF

16. Inaugurating High‐Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection (Adv. Sci. 27/2023)

Author

Jo, Ala, primary, Green, Allen, additional, Medina, Jamie E., additional, Iyer, Sonia, additional, Ohman, Anders W., additional, McCarthy, Eric T., additional, Reinhardt, Ferenc, additional, Gerton, Thomas, additional, Demehin, Daniel, additional, Mishra, Ranjan, additional, Kolin, David L., additional, Zheng, Hui, additional, Cheon, Jinwoo, additional, Crum, Christopher P., additional, Weinberg, Robert A., additional, Rueda, Bo R., additional, Castro, Cesar M., additional, Dinulescu, Daniela M., additional, and Lee, Hakho, additional

Published
2023
Full Text
View/download PDF

19. BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state

Author

Li, Yingchun, Moretto-Zita, Matteo, Soncin, Francesca, Wakeland, Anna, Wolfe, Lynlee, Leon-Garcia, Sandra, Pandian, Raj, Pizzo, Donald, Cui, Li, Nazor, Kristopher, Loring, Jeanne F, Crum, Christopher P, Laurent, Louise C, and Parast, Mana M

Subjects
Pediatric, Stem Cell Research - Umbilical Cord Blood/ Placenta - Human, Stem Cell Research - Umbilical Cord Blood/ Placenta, Stem Cell Research, Stem Cell Research - Nonembryonic - Human, Stem Cell Research - Embryonic - Human, Regenerative Medicine, 5.2 Cellular and gene therapies, Underpinning research, Development of treatments and therapeutic interventions, 1.1 Normal biological development and functioning, Bone Morphogenetic Protein 4, Cell Differentiation, Cells, Cultured, Embryonic Stem Cells, Female, Flow Cytometry, Gene Expression Profiling, Gestational Age, Humans, In Vitro Techniques, Kruppel-Like Factor 4, Placenta, Pregnancy, Real-Time Polymerase Chain Reaction, Trophoblasts, Delta Np63, BMP4, Human embryonic stem cells, Trophoblast, ΔNp63, Biological Sciences, Medical and Health Sciences
Abstract

The placenta is a transient organ that is necessary for proper fetal development. Its main functional component is the trophoblast, which is derived from extra-embryonic ectoderm. Little is known about early trophoblast differentiation in the human embryo, owing to lack of a proper in vitro model system. Human embryonic stem cells (hESCs) differentiate into functional trophoblast following BMP4 treatment in the presence of feeder-conditioned media; however, this model has not been widely accepted, in part owing to a lack of proof for a trophoblast progenitor population. We have previously shown that p63, a member of the p53 family of nuclear proteins, is expressed in proliferative cytotrophoblast (CTB), precursors to terminally differentiated syncytiotrophoblast (STB) in chorionic villi and extravillous trophoblast (EVT) at the implantation site. Here, we show that BMP4-treated hESCs differentiate into bona fide CTB by direct comparison with primary human placental tissues and isolated CTB through gene expression profiling. We show that, in primary CTB, p63 levels are reduced as cells differentiate into STB, and that forced expression of p63 maintains cyclin B1 and inhibits STB differentiation. We also establish that, similar to in vivo events, hESC differentiation into trophoblast is characterized by a p63(+)/KRT7(+) CTB stem cell state, followed by formation of functional KLF4(+) STB and HLA-G(+) EVT. Finally, we illustrate that downregulation of p63 by shRNA inhibits differentiation of hESCs into functional trophoblast. Taken together, our results establish that BMP4-treated hESCs are an excellent model of human trophoblast differentiation, closely mimicking the in vivo progression from p63(+) CTB stem cells to terminally differentiated trophoblast subtypes.

Published
2013

29. Uterus

Author

Kaspar, Hanna G., Crum, Christopher P., Lin, Fan, editor, and Prichard, Jeffrey, editor

Published
2015
Full Text
View/download PDF

30. A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine

Author

Herfs, Michael, Roncarati, Patrick, Koopmansch, Benjamin, Peulen, Olivier, Bruyere, Diane, Lebeau, Alizee, Hendrick, Elodie, Hubert, Pascale, Poncin, Aurelie, Penny, William, Piazzon, Nathalie, Monnien, Franck, Guenat, David, Mougin, Christiane, Prétet, Jean-Luc, Vuitton, Lucine, Segers, Karin, Lambert, Frederic, Bours, Vincent, de Leval, Laurence, Valmary-Degano, Severine, Quick, Charles M, Crum, Christopher P, and Delvenne, Philippe

Published
2018
Full Text
View/download PDF

31. Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis

Author

Wang, Shan, primary, Rao, Wei, additional, Hoffman, Ashley, additional, Lin, Jennifer, additional, Li, Justin, additional, Lin, Tao, additional, Liew, Audrey-Ann, additional, Vincent, Matthew, additional, Mertens, Tinne C. J., additional, Karmouty-Quintana, Harry, additional, Crum, Christopher P., additional, Metersky, Mark L., additional, Schwartz, David A., additional, Davies, Peter J. A., additional, Stephan, Clifford, additional, Jyothula, Soma S. K., additional, Sheshadri, Ajay, additional, Suarez, Erik Eddie, additional, Huang, Howard J., additional, Engelhardt, John F., additional, Dickey, Burton F., additional, Parekh, Kalpaj R., additional, McKeon, Frank D., additional, and Xian, Wa, additional

Published
2023
Full Text
View/download PDF

32. Supplementary Table 5 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 1 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 2 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 3 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

36. Data from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Text and Figures from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Table 4 from Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

Author

Hill, Sarah J., primary, Decker, Brennan, primary, Roberts, Emma A., primary, Horowitz, Neil S., primary, Muto, Michael G., primary, Worley, Michael J., primary, Feltmate, Colleen M., primary, Nucci, Marisa R., primary, Swisher, Elizabeth M., primary, Nguyen, Huy, primary, Yang, Chunyu, primary, Morizane, Ryuji, primary, Kochupurakkal, Bose S., primary, Do, Khanh T., primary, Konstantinopoulos, Panagiotis A., primary, Liu, Joyce F., primary, Bonventre, Joseph V., primary, Matulonis, Ursula A., primary, Shapiro, Geoffrey I., primary, Berkowitz, Ross S., primary, Crum, Christopher P., primary, and D'Andrea, Alan D., primary

Published
2023
Full Text
View/download PDF

39. Data from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table 4 from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table 5 from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 2 from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

45. Supplementary Table 1 from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Materials from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Table 3 from Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Author

Wan, Changxin, primary, Keany, Matthew P., primary, Dong, Han, primary, Al-Alem, Linah F., primary, Pandya, Unnati M., primary, Lazo, Suzan, primary, Boehnke, Karsten, primary, Lynch, Katherine N., primary, Xu, Rui, primary, Zarrella, Dominique T., primary, Gu, Shengqing, primary, Cejas, Paloma, primary, Lim, Klothilda, primary, Long, Henry W., primary, Elias, Kevin M., primary, Horowitz, Neil S., primary, Feltmate, Colleen M., primary, Muto, Michael G., primary, Worley, Michael J., primary, Berkowitz, Ross S., primary, Matulonis, Ursula A., primary, Nucci, Marisa R., primary, Crum, Christopher P., primary, Rueda, Bo R., primary, Brown, Myles, primary, Liu, Xiaole Shirley, primary, and Hill, Sarah J., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results